Physician profile
Gary A Glicksteen
NPI 1689758211
$958.23
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $573 · 2020: $370 · 2022: $15.52.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $304.68 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $147.75 | 2019-2020 | |
| Glaxosmithkline, LLC. | $87.26 | 2019-2020 | |
| Radius Health, INC. | $50.95 | 2019 | |
| Abbvie INC. | $46.05 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $43.23 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.30 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $31.65 | 2019 | |
| Pfizer INC. | $24.32 | 2019 | |
| Novo Nordisk INC | $23.83 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.37 | 2020 | |
| Sanofi-Aventis U.S. LLC | $15.76 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.68 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.52 | 2022 | |
| Allergan, INC. | $15.45 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $14.97 | 2019 | |
| Ibsa Pharma INC. | $13.96 | 2020 | |
| Horizon Therapeutics Plc | $13.32 | 2020 | |
| Lilly USA, LLC | $13.25 | 2019 | |
| Amarin Pharma, INC. | $12.96 | 2019 | |
| Currax Pharmaceuticals LLC | $11.97 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Glicksteen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.